Illumina
(NASDAQ:ILMN)
$119.00
1.07[0.91%]
At close: May 6
$119.00
0[0.00%]
After Hours: 4:28PM EDT
Q1 2024 Earnings were released on Thu May 2nd, after the market close
The most recent conference call was at 17:00 PM, 4 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Illumina Stock (NASDAQ:ILMN), Quotes and News Summary

Illumina Stock (NASDAQ: ILMN) stock price, news, charts, stock research, profile.

Open$118.040
Close$118.980
Volume / Avg.1.803M / 1.636M
Day Range115.910 - 119.395
52 Wk Range89.000 - 213.910
Market Cap$18.951B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
0
Short Interest
3.75%
Days to Cover3.35

Recent News

Wall Street Looks To Feed Off Apple's Post-Earnings Power But Key Jobs Data May Upset The Cart: Analyst Says 'A Lot Of These Clouds Will Lift' If This Happens
Stocks look set to carry forward the upward momentum on Friday amid some earnings cheer, although a tinge of nervousness is evident ahead of the all-important non-farm payrolls report.
Shanthi Rexaline
Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market
U.S. stocks look to push ahead on a positive path, now that the Federal Reserve’s rate decision is in the rearview mirror. Major index futures point to a positive open on Thursday.
Shanthi Rexaline
Jim Cramer Rejects Illumina As 'It's Not Well-Run,' Recommends Buying This Tech Stock 'Right Here, Right Now'
Jim Cramer doesn't recommend buying Dynatrace stock due to its high price. Canopy Growth is the best pot stock. BrightSpring, Illumina, and Bank of America also mentioned. Cramer recommends buying Palo Alto.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
1
Jan
2
Feb
0
0
0
0
Mar
2
1
Apr
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
2.8
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ILMN
MEDP

FAQ

Q

How do I buy Illumina (ILMN) stock?

A

You can purchase shares of Illumina (NASDAQ: ILMN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Illumina's (ILMN) competitors?

A

Other companies in Illumina’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Waters (NYSE:WAT) and Danaher (NYSE:DHR).

Q

What is the target price for Illumina (ILMN) stock?

A

The latest price target for Illumina (NASDAQ: ILMN) was reported by Scotiabank on Monday, May 6, 2024. The analyst firm set a price target for 176.00 expecting ILMN to rise to within 12 months (a possible 47.90% upside). 36 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Illumina (ILMN)?

A

The stock price for Illumina (NASDAQ: ILMN) is $119 last updated May 6, 2024 at 4:28 PM EDT.

Q

Does Illumina (ILMN) pay a dividend?

A

There are no upcoming dividends for Illumina.

Q

When is Illumina (NASDAQ:ILMN) reporting earnings?

A

Illumina’s Q2 earnings are confirmed for Wednesday, August 7, 2024.

Q

Is Illumina (ILMN) going to split?

A

There is no upcoming split for Illumina.

Q

What sector and industry does Illumina (ILMN) operate in?

A

Illumina is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

People Also Watch